ORIA
Price:
$10.23
Market Cap:
$0
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
Industry
Shell Companies
IPO Date
2021-07-02
Stock Exchange
NASDAQ
Ticker
ORIA
According to Orion Biotech Opportunities Corp.’s latest financial reports and current stock price. The company's current PE Ratio is 29.23. This represents a change of 133.12% compared to the average of 12.54 of the last 4 quarters.
The mean historical PE Ratio of Orion Biotech Opportunities Corp. over the last ten years is -105.21. The current 29.23 PE Ratio has changed -2878.24% with respect to the historical average. Over the past ten years (40 quarters), ORIA's PE Ratio was at its highest in in the September 2022 quarter at 30.06. The PE Ratio was at its lowest in in the December 2021 quarter at -27.85.
Average
-105.21
Median
-105.21
Minimum
-221.33
Maximum
10.92
Discovering the peaks and valleys of Orion Biotech Opportunities Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 10.92
Minimum Annual Increase = -104.93%
Minimum Annual PE Ratio = -221.33
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | 10.92 | -104.93% |
The current PE Ratio of Orion Biotech Opportunities Corp. (ORIA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-105.21
5-year avg
-105.21
10-year avg
-105.21
Orion Biotech Opportunities Corp.’s PE Ratio is less than TB S.A. Acquisition Corp (0), greater than Alpha Partners Technology Merger Corp. (-0.85), greater than Corazon Capital V838 Monoceros Corp (-189.96), greater than Build Acquisition Corp. (-254.62), greater than Green Visor Financial Technology Acquisition Corp. I (8.01), less than Frontier Acquisition Corp. (139.26), less than TortoiseEcofin Acquisition Corp. III (33.83),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0 | $255.12M | |
| -0.85 | $243.21M | |
| -189.96 | $260.48M | |
| -254.62 | $255.00M | |
| 8.01 | $264.88M | |
| 139.26 | $299.10M | |
| 33.83 | $265.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orion Biotech Opportunities Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orion Biotech Opportunities Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Orion Biotech Opportunities Corp.'s PE Ratio?
How is the PE Ratio calculated for Orion Biotech Opportunities Corp. (ORIA)?
What is the highest PE Ratio for Orion Biotech Opportunities Corp. (ORIA)?
What is the 3-year average PE Ratio for Orion Biotech Opportunities Corp. (ORIA)?
What is the 5-year average PE Ratio for Orion Biotech Opportunities Corp. (ORIA)?
How does the current PE Ratio for Orion Biotech Opportunities Corp. (ORIA) compare to its historical average?